BHST (BioHarvest Sciences) Cash Ratio: 2.11 (As of Mar. 2026) — 264% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BHST BioHarvest Sciences Inc BHST
63 GF Score
Price $1.92
GF Value $8.60
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is BioHarvest Sciences Cash Ratio?

BioHarvest Sciences BHST -4.00% 63 Cash Ratio is 2.11 as of Mar. 2026, which is 264% above its 10-year median of 0.58. GuruFocus rates BHST with a GF Score™ of 63/100 and a GF Value™ of $8.60 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,932 Consumer Packaged Goods companies, BioHarvest Sciences ranks better than 86.59% on this metric.

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. BioHarvest Sciences's Cash Ratio for the quarter that ended in Mar. 2026 was 2.11.

BioHarvest Sciences has a Cash Ratio of 2.11. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for BioHarvest Sciences's Cash Ratio or its related term are showing as below:

BHST' s Cash Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.58   Max: 19.7
Current: 2.11

During the past 12 years, BioHarvest Sciences's highest Cash Ratio was 19.70. The lowest was 0.01. And the median was 0.58.

BHST's Cash Ratio is ranked better than
86.59% of 1932 companies
in the Consumer Packaged Goods industry
Industry Median: 0.4 vs BHST: 2.11

BioHarvest Sciences  (NAS:BHST) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


BioHarvest Sciences Cash Ratio Related Terms


BioHarvest Sciences Cash Ratio Historical Data

* Premium members only.

The historical data trend for BioHarvest Sciences's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioHarvest Sciences Cash Ratio Chart

BioHarvest Sciences Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.41 0.15 0.20 0.17 3.00

BioHarvest Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.22 0.83 3.00 2.11

BHST vs BRID, BOF, BFNH: Cash Ratio Comparison

For the Packaged Foods subindustry, BioHarvest Sciences's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioHarvest Sciences Cash Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's Cash Ratio distribution charts can be found below:

* The bar in red indicates where BioHarvest Sciences's Cash Ratio falls into.


BHST
63GF Score
BioHarvest Sciences Inc BHST
Cash Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioHarvest Sciences Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

BioHarvest Sciences's Cash Ratio for the fiscal year that ended in Dec. 2025 is calculated as:

Cash Ratio (A: Dec. 2025 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=23.025/7.684
=3.00

BioHarvest Sciences's Cash Ratio for the quarter that ended in Mar. 2026 is calculated as:

Cash Ratio (Q: Mar. 2026 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=20.168/9.578
=2.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Ratio →
What does a Cash Ratio of 2.11 mean?
BioHarvest Sciences (BHST) has a Cash Ratio of 2.11 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on BioHarvest Sciences and its competitors. This is 264% above median its historical median of 0.58. Over the past decade, BioHarvest Sciences' Cash Ratio has ranged from 0.01 to 19.70. According to the industry distribution chart, BioHarvest Sciences ranks #259 out of 1932 companies in the Consumer Packaged Goods industry, placing it in the top 13.4%.
Is BioHarvest Sciences' Cash Ratio too high?
BioHarvest Sciences' current Cash Ratio of 2.11 is 264% above median its 10-year median of 0.58. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 19.70. The Consumer Packaged Goods industry median Cash Ratio is 0.40. BioHarvest Sciences' value of 2.11 is 427.5% above this industry median. Based on the distribution chart, BioHarvest Sciences ranks #259 out of 1932 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, BioHarvest Sciences has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioHarvest Sciences' Cash Ratio compare to BRID and BOF?
According to the Consumer Packaged Goods industry distribution chart, BioHarvest Sciences ranks #259 out of 1932 companies for Cash Ratio. This places BioHarvest Sciences in the top 13% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.40. BioHarvest Sciences' value of 2.11 is 427.5% above this benchmark. Historically, BioHarvest Sciences' own Cash Ratio has ranged from 0.01 to 19.70 over the past decade. While the company's 10-year median is 0.58 vs. the industry median of 0.40, BioHarvest Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Consumer Packaged Goods company?
The median Cash Ratio among Consumer Packaged Goods companies is 0.40, based on 1,932 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioHarvest Sciences's current Cash Ratio of 2.11 is 427.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on BioHarvest Sciences and its competitors. For the Consumer Packaged Goods industry, the median Cash Ratio is 0.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioHarvest Sciences's current Cash Ratio is 2.11, which is 264% above median its own 10-year median of 0.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioHarvest Sciences stock overvalued right now?
Based on GuruFocus' analysis, BioHarvest Sciences (BHST) is currently considered Possible Value Trap. The stock's GF Value™ is $8.60, compared to a current price of $1.92 — trading 77.7% below its estimated fair value. The current Cash Ratio is 2.11, which is 264% above median its 10-year median of 0.58 and 427.5% above the Consumer Packaged Goods industry median of 0.40. BioHarvest Sciences' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For BioHarvest Sciences (BHST), the current Cash Ratio is 2.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioHarvest Sciences (BHST) Overvalued in 2026?

Based on GuruFocus' analysis, BioHarvest Sciences stock appears to be undervalued. The current stock price of $1.92 is trading 77.7% below its estimated GF Value™ of $8.60. GuruFocus considers BioHarvest Sciences to be Possible Value Trap.

Key valuation signals for BHST:

  • Cash Ratio: 2.11 (264% above median its 10-year median of 0.58)
  • GF Value™: $8.60 vs. price of $1.92 (77.7% below fair value)
  • GF Score™: 63/100 with 4 warning signs
  • Industry Position: 427.5% above the Consumer Packaged Goods median (#259 of 1932)

No single metric tells the full story. See the BHST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioHarvest Sciences Business Description

Other Exchanges 8MV0:Germany
Address 1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
63GF Score

Get the complete analysis for BHST

Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.92
Price
$8.60
GF Value